While sugammadex was only just approved by the FDA in 2015, it has been widely used around the European Union since its approval by …show more content…
Geldner et al. in a multicenter clinical trial assessed recovery times from deep neuromuscular blockade using sugammadex when compared with moderate neuromuscular blockade (re-appearance of the second twitch of train-of-four stimulation) using neostigmine in patients undergoing laparoscopic cholecystectomy or appendectomy under general anesthesia. Sugammadex recovery time was found to be 3.4 times faster when compared to neostigmine group. Also, the extubation time and discharge time from OR were reduced when using sugammadex as a reversal